AnorMED Inc. — Investor Relations & Filings
AnorMED Inc. was a chemistry-based biopharmaceutical company focused on the discovery, research, and development of small molecule therapeutics. The company specialized in applying chemistry, biochemistry, and biology to create novel treatments, primarily targeting serious diseases such as cancer and HIV. A key compound in its portfolio, AMD-3100, reached Phase III clinical development. AnorMED Inc. ceased independent operations in October 2006 following its acquisition by Genzyme Corporation for approximately US$584 million.
Recent filings
No filings indexed yet
We are still gathering filings for AnorMED Inc.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Salarius Pharmaceuticals, Inc.
Clinical-stage biopharmaceutical company developing therapi…
|
SLRX | US | Professional, scientific and te… |
|
SaltX Technology Holding B
Develops electrification and carbon capture technology for …
|
SALT | SE | Professional, scientific and te… |
|
SAMSRITA LABS LIMITED
Focuses on biotechnology, regenerative medicine, and clinic…
|
539267 | IN | Professional, scientific and te… |
|
SanBio Company Limited
Develops regenerative cell-based therapies for neurological…
|
4592 | JP | Professional, scientific and te… |
|
SANGAMO THERAPEUTICS, INC
A clinical-stage genomic medicine company developing therap…
|
SGMO | US | Professional, scientific and te… |
|
Satellos Bioscience Inc.
Clinical-stage developer of small molecule drugs for skelet…
|
— | CA | Professional, scientific and te… |
|
Satellos Bioscience Inc.
Clinical-stage biotech developing regenerative small molecu…
|
MSCL | CA | Professional, scientific and te… |
|
S.Biomedics Co., Ltd.
Researches and develops stem cell-based therapies for regen…
|
304360 | KR | Professional, scientific and te… |
|
SCANCELL HOLDINGS PLC
A clinical-stage company developing novel immunotherapies f…
|
SCLP | GB | Professional, scientific and te… |
|
Scandion Oncology A/S
A biotech company under liquidation that developed cancer d…
|
SCOL | DK | Professional, scientific and te… |
AnorMED Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44676/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44676 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44676 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44676 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44676}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AnorMED Inc. (id: 44676)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.